Google+ Followers

Tuesday, May 22, 2012

Vitamin D Studies and Research References

Reference Info for Blogs on Vitamin D 
Moschakis T et al: Microstructural evolution of viscoelastic emulsions stabilised by sodium caseinate and xanthan gum Procter Department of Food Science, University of Leeds, Leeds LS2 9JT, UK 
J Colloid Interface Sci. 2005 Apr 15;284(2):714-28
Liu HX et al; Promotion of intestinal drug absorption by milk fat globule membrane 
Department of Hospital Pharmacy, Toyama Medical and Pharmaceutical University, Japan Yakugaku Zasshi. 1991 Sep;111(9):510-4 

1 Cross D, et al. Phytoestrogens and vitamin D metabolism: A new concept for the prevention and therapy of colorectal, prostate, and mammary carcinomas. J Nutrition. 2004; 134: 127-1212.

2 Danilenko M, et al. Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst. 2001, 93(16): 1224-1233.

3 Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and FLouride. Wasington, DC: The National Academies Press; 1997.

4 Grant W & Holick M. Benefits and Requirements of Vitamin D for Optimal Health: A Review. Alt Med Rev, 2005;10:94-108.

5 Vieth R. Why the optimal requirements for vitamin D3 is probably much higher than What is officially Recommended for Vitamin D. J Nutr 2005;135:317-322.

6 Veith R, Chan PC, MacFaralane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-294.

7 Veith R, Kimbeall S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4,000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 2004;3:8.

8 Hoick M. Vitamin D: importance in the prevention of cancers, type I diabetes, heart disease, and osteoporosis. Am J Clin Nutrition. 2004; 39:326-327.

9 Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position paper statement. Med J Aust 2005;182:281-285.

10 Cancer Chemoprevention and Cancer Treatment: is there a role for vitamin D, 1alpha, 25(OH)2-vitamin D3, or new analogs (deltanois)? Bethesda, MD, November 17-19, 2004. Sponsored by the National Cancer Institute, NIH, The Vitamin D Workshop, http://vitamined.ucr.edu/Cancer&CancerChemo.htm (accessed April 10, 2005).

11 Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in the human skin. J Clin Endorinol Metab 1988; 67:373-378.

12 Holick MF. Environment factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995;61:6838S-645S.

13 Alti T, Gullu S, Usal AR, Erdogen G. The prevalence of vitamin D levels in the elderly Turkish population. Arch Gerontol Geriatr 2005;40:53-60.

14 Moore C, Murphy MM, Keast DR, Holick MF. Vitamin D intake in the United States. J AM Diet Assoc 2004;104:980-983.

15 Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-337.

16 Chapuy MC, Preziosi P, Maamer M, et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997;7:439-443.

17 Tangpricha V, Pearce EN, Chen TC, Holick MF. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-662.

18 Worstman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;/2: 690-693. Erratum in : Am J Clin Nutr 2003;77:1342.

19 Koutkia P, Lu Z, Chen TC, Holick MF. Treatment of vitamin D deficiency due to Crohn’s disease with tanning bed ultraviolet B radiation. Gastroeneterology 2001; 121:1485-1488.

20 Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 2004;95:469-480.

21 Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693.

22 Holick MF. Photosynthesis of vitamin D in the skin: effect of environmental and life-style variables. Fed Proc 1987;46:1876-1882.

23 Atli T, Gullu S, Usal AR, Erdogan G. The prevalence of vitamin D deficiency and effects of ultraviolet light on vitamin D levels in elderly Turkish population. Arch Gerontol Geriatr 2005;40:53-60.

24 Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular diseases. Am J Clin Nutr 2004;80:1678S-1688S.

25 Cantorna MT, Zhu Y, Froicu M, Whittke A. Vitamin D status, 1-25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 

26 DeLuca HF, Cantorna MT. Vitamin D:its role and uses in immunology. FASEB J 2001;15:2579-2585.

27 Lyakh LA, Sanford M, Chekol S, et al. TGF beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of monocytes into CD83+ dendritic cells. J Immunol 2005;174:2061-2070.

28 Drugarin D. The pattern of Th1 cytokine in autoimmune thyroditis. Immunol Letts, 2000; 71: 73-77.

29 Smith EA, et al. Effects of long-term administration of vitamin D3 analogs to mice. J Endocrinol Invest. 1994; 17(6): 385-390.

30 Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003;88:216-222.

31 Embroy AF. Vitamin D supplementation in the fight against multiple sclerosis. J Orthomolecular Med 2004;19:27-38.

32 Temper DI, Trent NH, Spencer DA, et al. Season of birth in multiple sclerosis. Acta Neurol Scand 1992;85:107-109.

33 Willer Cj, Dyment DA, Sadovnick AD, et al. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005;330:120.

34 Embroy AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;48:271-271.

35 Ericksen EF, Glenrup H. Vitamin D deficiency and aging: implications for general health and osteporosis. Biogerontology 2002;3:73-77.

36 Holick MF. Vitamin D deficiency: what pain it is. Mayo Clin Proc 2003;78:1457-1459.

37 Plotnikoff GA, Quigley JM. Prevalence of sever hypovitaminosis D in patients with persistent nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463-1470.

38 Plotnikoff GA, Quigley JM. Prevalence of sever hypovitaminosis D in patients with persistent nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78:1463-1470.

39 Chiu K, et al. Hypovitaminosis D is associated with insulin resistance and beta cell function. Am J Clin Nutrition. 2004; 79: 820-825.
40 Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 2001; 358:1500-1503.

41 Hypponen E. Micronutrients and risk of type I diabetes: vitamin D, vitamin E, and nicotinamide. Nutr Rev 2004; 62:340-347.

42 Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypothesis 1986;21: 193-200.

43 Embry AF. Vitamin D supplementation in the fight against multiple sclerosis. J Orthomolecular Med 2004; 19:27-38.

44 Hayas CE, Cantorna MT, DeLuca HF. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Medi 1997;216:21-27.

45 Koziol JA. Feng AC. Seasonal variations in exacerbations and MRI parameters in relapsing remitting multiple sclerosis. Neuroepidemiology 2004; 23:217-223.

46 Embroy AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;48:271-272.

47 Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003;112:e132-135.

48 Bischoff-Ferrari HA, Conzelmann M, Dick W, et al. Effect of vitamin D on muscle strength and relevance in regard to osteoporosis prevention. Z Rheumatol 2003;62:518-521.

49 Fuller KE. Low birth-weight infants: the continuing ethnic disparity and the interaction of biology and environment. Ethn Dis 2000;10:432-445.

50 Specker B. Vitamin D requirements during pregnancy. Am J Clin Nutr 2004;80:1740S-1747S.

51 Hypponens E, Lara E, Reunanen A, et al. Intake of vitamin D and risk of type I diabetes: a birth-cohort study. Lancet 2001;358:1500-1503.

52 Pawley N, Bishop NJ. Prenatal and infant predictors of bone health: the influence of vitamin D. Am J Clin Nutr 2004;80:1748S-1751S.

53 Grant W.B., Holick MF. Benefits and Requirements of Vitamin D for Optimal Health: A Review. Alt Med Rev 2005;10:94-111.

54 Grant WB. An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002;94:1867-1875.

55 Grant WB. Benefits of UVB exposure to reduce the risk of cancer – ecologic studies of cancer mortality rates. Proceedings of the CIE symposium ’04; Light and Health: non-visual effects, 30 Sept.-2 Oct. 2004. Commision International de L, Eclairage, Vienna, Austria, 2004:174-177.

56 Grant WB., Garland CF. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48:115-123.

57 Baker SB, Worthley LI, The essentials of calcium, magnesium and phosphate metabolism: part I. Physiology 
Department of Critical Care Medicine, Flinders University of South Australia, Adelaide, South Australia (Crit Care Resusc. 2002 Dec;4(4):301-6.)

58 Mazur A et al, Magnesium and the inflammatory response: Potential physiopathological implications Equipe Stress Metabolique et Micronutriments, Unite de Nutrition Humaine UMR 1019, Centre de Recherche en Nutrition Humaine d’Auvergne, INRA, Theix, St. Genes Champanelle, France. Arch Biochem Biophys. 2006 Apr 19

59 Carpenter TO et al “Effect of magnesium depletion on metabolism of 25-hydroxyvitamin D in rats”

60 Cox SE et al; Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation. Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine (LSHTM), London, UK.Clin Exp Immunol. 2006 Jun;144(3):392-400. 

61 Luo XM, “Retinoic acid exerts dual regulatory actions on the expression and nuclear localization of interferon regulatory factor-1” Department of Nutritional Sciences, 126-S Henderson Building, University Park, PA 16802, USA, Exp Biol Med (Maywood). 2006 May;231(5):619-31

62 Wieringa FT et al; Reduced production of immunoregulatory cytokines in vitamin A- and zinc-deficient Indonesian infants.
Department of Internal Medicine, University Hospital Nijmegen, The Netherlands --- Eur J Clin Nutr. 2004 Nov;58(11):1498-504.

63 Chandra R and Sudhakaran L. Regulation of immune responses by Vitamin B6. NY Acad Sci 1990; 585:404-423.

64 Leklem JE. Vitamin B6. In: Shils ME, Olson JA, Shike M, Ross AC, ed. Modern Nutrition in Health and Disease. 9th ed. Baltimore: Williams and Wilkins, 1999: 413-421. 

65 Leyland DM and Beynon RJ. The expression of glycogen phosphorylase in normal and dystrophic muscle. Biochem J 1991; 278:113-7.

66 Okada M, Ishikawa K, Watanabe K. Effect of vitamin B6 deficiency on glycogen metabolism in the skeletal muscle, heart, and liver of rats. J Nutr Sci Vitaminol (Tokyo) 1991; 37:349-57.

67 Revilla-Monsalve C et al, “Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia” Biomed Pharmacother. 2006 May;60(4):182-185. Epub 2006 Mar 31.

68 L. C. Stene et al , Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring
Diabetologia, Volume 43, Number 9; September 2000 

69 Campan P et al; Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis.
Departement de Chirurgie Buccale, Faculte de Chirurgie Dentaire de Toulouse, France. J Clin Periodontol. 1997 Dec;24(12):907-13.

70 Dayong Wu and Simin Nikbin Meydan ; “ n-3 Polyunsaturated fatty acids and immune function” 
Nutritional Immunology Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at TUBS University,Boston, Proceedings of the Nutrition Society (1998), 57, 503-509 

71 Sergeeva M “Regulation of intracellular calcium levels by polyunsaturated fatty acids, arachidonic acid and docosahexaenoic acid, in astrocytes: possible involvement of phospholipase A2” Reprod Nutr Dev. 2005 Sep-Oct;45(5):633-46 
Otto-von-Guericke-Universitat Magdeburg, Medizinische Fakultat, Institut fur Neurobiochemie, Leipziger Strasse 44, 39120 Magdeburg, Germany

 

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.